This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Event HeartValve Disease Forum 2025 kchalko Thu, 03/13/2025 - 14:32 Event dates Sep 1213, 2025 Location Seoul, Korea STS is pleased to co-present the HeartValve Disease Forum (HVDF) with the Korean Society for Thoracic and Cardiovascular Surgery, offering the latest knowledge regarding the basics, diagnosis, treatment, and future of valvular heart (..)
When a patient needs a new heartvalve, the current mechanical and tissue replacements each have strengths and weaknesses. Now, a team of researchers believe they have found a way to harness the strengths of both technologies in a way that could be life-changing -- and life-saving -- for many.
A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heartvalve disease -- aortic stenosis (AS).
Griepp , MD Professor in Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , was named as the new President of the HeartValve Society ( HVS ) at the 2024 HVS Annual Meeting on Wednesday, February 21, in Boston.
22, 2025 More than 60,000 people die from heartvalve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. DALLAS, Feb. Additionally, data from the Statistical Update shows.
Recently published research shows a medical device may be beneficial for patients who have previously had a stroke and are planning to undergo a transcatheter aortic valve replacement, a type of heartvalve operation.
are diagnosed with heartvalve disease, but this condition has no effective long-term treatment. When a person's heartvalve is severely damaged by a birth defect, lifestyle, or aging, blood flow is disrupted. Every year, more than 5 million people in the U.S. If left untreated, there can be fatal complications.
Bileaflet mechanical heartvalves (MHV) remain a viable option for aortic valve replacement, particularly for younger patients and patients from low- and middle-income countries and underserved communities. Despite their exceptional durability, MHV recipients are at increased risk of thromboembolic complications.
According to Dr. Kendra Grubb , Surgical Director of the Emory Structural Heart & Valve Center , approximately 40%† of patients with aortic stenosis in the United States do not get treatment because their symptoms are often misdiagnosed or ignored2. To explore the TAVR Heart Team Finder, please click here.
A large population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heartvalve disease—aortic stenosis (AS).
Patients aged between 50 to 70 years with a mechanical heartvalve replacement had better long-term survival compared to those with a biological valve, new research has found.
When a patient needs a new heartvalve, the current mechanical and tissue replacements each have strengths and weaknesses. Dr. Hadi Mohammadi and his fellow researchers in the HeartValve Performance Laboratory at UBC Okanagan are focused on developing the mechanical heartvalves of the future.
A prototype of an expanding artificial heartvalve could make a big dent in the number of surgeries that many kids born with congenital heart disease need.
IntroductionClinical evidence highlighting the efficacy and safety of transcatheter aortic valve replacement (TAVR) and the 2019 Food and Drug Administration (FDA) approval for TAVR in low-risk (younger) patients has created a demand for durable and long-lasting bioprosthetic heartvalve (BHV) leaflet materials.
Human skin cells have been reprogrammed into heartvalve cells and then used to successfully transplant a pig heartvalve into a rodent, led by the research of a Northeastern University professor.
Despite being a leading cause of morbidity and mortality among young people, affecting predominantly women, rheumatic heart disease (RHD) remains neglected and understudied.
The HeartValve Collaboratory has proposed a framework to standardize best practices for using multimodality imaging in transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR), in a State-of-the-Art Review.
Arizona, Louisiana, Michigan, Ohio, Pennsylvania and Texas have the most top-ranked hospitals for heartvalve replacement in the U.S., according to the WebMD Choice Awards.
The Intrepid TMVR is a heartvalve that is designed to help alleviate mitral regurgitation so that blood can flow through the heart in the intended direction,” said Matthew Saybolt , M.D., FACC, principal site investigator and medical director, Structural Heart Disease Program, Jersey Shore University Medical Center.
The sheer scale of undiagnosed heartvalve disease in our aging population has been revealed for the first time, thanks to new research led by the University of East Anglia.
In guidelines issued by the American Society of Echocardiography and published online in the January issue of the Journal of the American Society of Echocardiography, updated recommendations are presented for evaluating prosthetic valve function in patients with prosthetic heartvalves (PHVs).
Findings from a published case series research letter by the Henry Ford Health Structural Heart Disease team show that severe mitral stenosis, due to a build-up of calcium deposits in the mitral valve common in elderly patients, can be safely and successfully treated using Intravascular lithotripsy (IVL)-enabled percutaneous balloon mitral valvuloplasty. (..)
(MedPage Today) -- Operators reported the initial success of a novel transcatheter technique for treating complex paravalvular leaks (PVLs) after transcatheter aortic valve replacement (TAVR) or transcatheter mitral valve replacement (TMVR) in.
A team of researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid has identified the molecular mechanisms that control the activity of genes involved in both the correct formation of the heartvalves and the prevention of their subsequent calcification.
milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center.
Research Highlights: Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and blood clot prevention in patients after heartvalve replacement surgery as warfarin, the current.
According to Dr. Kendra Grubb , Surgical Director of the Emory Structural Heart & Valve Center , approximately 40%† of patients with aortic stenosis in the United States do not get treatment because their symptoms are often misdiagnosed or ignored2. To explore the TAVR Heart Team Finder, please click here.
Traditionally, patients with a failing heartvalve were advised to return in six to 12 months, as physicians generally took a "wait and see" approach, but a new study suggests patients may benefit more if their valves are replaced immediately through a minimally invasive procedure.
During the Valve Forum, mentees will have the opportunity to engage in one-to-one meetings with their mentors. Questions Contact the secretariat of the 2024 HeartValve Forum. Visit Event Home KTCVS-STS Asia Symposium on Valvular Heart Disease Adult Cardiac Surgeon Image Details coming soon!
(MedPage Today) -- The newborn that received the world's first partial heart transplant in 2022 continued to do well a year later, according to a case report from the transplant team. Born with type A2 persistent truncus arteriosus and irreparable.
Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heartvalve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heartvalve interventions will increase significantly in the coming decades.
An international task force has developed standards for tracking outcome measures of patients with heartvalve disease, a condition which is expected to double in prevalence by 2040. The standards were published Feb. 17 in Circulation: Cardiovascular Quality & Outcomes.
Oklahoma City-based Oklahoma Children's Hospital OU Health used an adolescent patient's own tissue to reconstruct a leaky heartvalve, CBS affiliate KWTV reported Jan.
A unique international task force, comprised of representatives from cardiology and cardiothoracic societies as well as patient representatives, has developed the first standardized set of measures for heartvalve disease (HVD).
Research Highlights: An analysis of death certificate data from 1999 to 2020 showed a decline in deaths related to infective endocarditis throughout most of the United States yet found an alarming increase of 2%-5% among adults ages 25-44. There was.
based MUSC Health's Heart and Vascular Center became the first in the country to implant the Topaz device, a new transcatheter tricuspid heartvalve replacement system. A team from Charleston, S.C.-based
People having surgery to repair tight or leaking heartvalves may receive a pacemaker more often than necessary—leading to a greater risk for life-threatening complications, studies show.
Although well-known for their thromboresistance, bileaflet mechanical heartvalves (BMHV) require lifelong anti-thrombotic therapy. This must be associated with a certain level of thrombogenicity. Since both t.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content